Table 3.

The Subgroup Analysis of Urinary Malondialdehyde Level (µg/mL) Between 2 Study Groups (N = 71).

Variables general characteristics	Poor-control type 2 DM (Mean ± SD)	Well-control type 2 DM (Mean ± SD)	t-Test (P value)
BMI (kg/m2)
<25	2.32 ± 1.08 (N = 10)	2.30 ± 0.88 (N = 16)	.96
≥25	2.70 ± 0.92 (N = 28)	2.55 ± 0.95 (N = 17)	.62
Underlying disease (n)	1.14 ± 0.32	1.16 ± 0.33	<.01
DM	2.29 ± 2.08 (N = 2)	1.88 ± 1.82 (N = 2)	.85
DM and DLP	2.43 ± 0.92 (N = 19)	2.58 ± 0.92 (N = 14)	.65
DM, DLP, and HT	2.83 ± 0.91 (N = 17)	2.37 ± 0.83 (N = 17)	.14
Smoking (n)	1.09 ± 0.39	1.13 ± 0.34	<.01
Never	2.51 ± 1.00 (N = 31)	2.23 ± 0.83 (N = 19)	.23
Ex-smoker	2.67 ± 0.71 (N = 4)	2.66 ± 1.05 (N = 12)	.29
Active	3.45 ± 0.53 (N = 3)	2.93 ± 0.22 (N = 2)	.99
Drinking (n)	1.28 ± 0.58	1.31 ± 0.57	<.01
Never	2.66 ± 0.94 (N = 25)	2.23 ± 0.93 (N = 18)	.78*
Ex-drinker	2.02 ± 1.04 (N = 5)	2.51 ± 1.03 (N = 8)	.14
Active	2.76 ± 0.98 (N = 8)	2.85 ± 0.63 (N = 7)	.43
LDL-C (mg/dL)
<100	2.46 ± 1.07 (N = 17)	2.35 ± 0.94 (N = 19)	.77
≥100	2.66 ± 0.86 (N = 20)	2.53 ± 0.88 (N = 14)	.68
HDL-C (mg/dL)
Male
<40	3.00 ± 0.95 (N = 3)	3.86 ± 0.49 (N = 4)	.25
≥40	2.01 ± 1.02 (N = 12)	2.44 ± 0.63 (N = 10)	.24
Female
<50	2.93 ± 0.83 (N = 14)	2.39 ± 1.10 (N = 5)	.36
≥50	2.60 ± 0.81 (N = 8)	2.03 ± 0.73 (N = 14)	.12
TC (mg/dL)
<200	2.58 ± 1.01 (N = 28)	2.45 ± 0.88 (N = 30)	.63
≥200	2.54 ± 0.83 (N = 9)	2.18 ± 1.39 (N = 3)	.70
Triglyceride (mg/dL)
<150	2.47 ± 0.98 (N = 19)	2.50 ± 0.86 (N = 28)	.91
≥150	2.67 ± 0.95 (N = 18)	2.02 ± 1.19 (N = 5)	.30
FBS (mg/dL)
<130	2.81 ± 0.88 (N = 8)	2.54 ± 0.80 (N = 24)	.46
≥130	2.60 ± 0.97 (N = 29)	2.30 ± 1.11 (N = 8)	.52

Abbreviations: DLP, dyslipidemia; DM, diabetes mellitus; HT, hypertension.

^*Wilcoxon rank sum test.